Evidence map›Paper›PMID 28067258›Full record

ArticleScientific reports2017

A new method for assessing the risk of infectious disease outbreak.

Yilan Liao, Bing Xu, Jinfeng Wang, Xiaochi Liu

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections.Biotechnology reports (Amsterdam, Netherlands) · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. A perspective on early detection systems models for COVID-19 spreading.Biochemical and biophysical research communications · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yilan LiaoThe State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China.
Bing XuThe State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China.
Jinfeng WangThe State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China.
Xiaochi LiuThe State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past few years, emergent threats posed by infectious diseases and bioterrorism have become public health concerns that have increased the need for prompt disease outbreak warnings. In most of the existing disease surveillance systems, disease outbreak risk is assessed by the detection of disease outbreaks. However, this is a retrospective approach that impacts the timeliness of the warning. Some disease surveillance systems can predict the probabilities of infectious disease outbreaks in advance by determining the relationship between a disease outbreak and the risk factors. However, this process depends on the availability of risk factor data. In this article, we propose a Bayesian belief network (BBN) method to assess disease outbreak risks at different spatial scales based on cases or virus detection rates. Our experimental results show that this method is more accurate than traditional methods and can make uncertainty estimates, even when some data are unavailable.

Indexed as

Bayes TheoremCommunicable Disease ControlCommunicable DiseasesDisease OutbreaksEpidemiological MonitoringHumansRisk AssessmentRisk Factors

Identifiers

PMID28067258
PMCPMC5220355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.